Steven Green is a partner in Goodwin’s Life Sciences group. He helps emerging life sciences, technology, and digital health companies on a full spectrum of business and legal issues throughout their corporate lifecycles. Steven has extensive experience advising clients on new company formations, early-stage financings, employment and executive compensation matters, capital raisings, mergers and acquisitions, and initial public offerings. He also advises venture capital firms on structuring and executing investments into life sciences and technology companies.
Experience
A selection of Steven’s recent representations include:
- Represented AbsCi in its acquisition of Totient
- Represented Advanced Biologics in its merger with Isto Biologics
- Represented InpharmD in its Series Seed financing
- Represented Mablink Bioscience in its sale to Eli Lilly and Company
- Represented Medipost in its joint venture investments in OmniaBio
- Represented Myrobalan Therapeutics in its Series A financing
- Represented Nuvig Therapeutics in its Series A financing
- Represented Questa Capital in an investment in Vynca
- Represented Sword Health in its Series C and Series D financings
- Represented Wellth in its Series B financing
Credentials
Education
JD2010
University of Chicago Law School
BS2007
University of Oregon
(honors)
Admissions
Bars
- California